Net Issuance Of Debt - Protagonist Therapeutics Inc (NASDAQ:PTGX) - Alpha Spread

Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 45.92 USD 2.57% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
Protagonist Therapeutics Inc?
Write Note

Protagonist Therapeutics Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Protagonist Therapeutics Inc
Net Issuance of Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Protagonist Therapeutics Inc
NASDAQ:PTGX
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Issuance of Debt
$9.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Debt
-$2.1B
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Issuance of Debt
$1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Debt
-$48.4m
CAGR 3-Years
-25%
CAGR 5-Years
-13%
CAGR 10-Years
2%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

Back to Top